Pharmaceutical and Medical Device Patent Portfolio Acquisition Opportunities from ICAP Patent Brokerage

NEW YORK, Sept. 4, 2013 /PRNewswire/ -- ICAP Patent Brokerage announces innovative pharmaceutical and medical device patent portfolios available for sale via private brokerage.

(Logo:  http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

"­­­­­­­­­­­­­­­­­­­­­­­­­­We are thrilled to offer such strong patent portfolios disclosing key advancements for the medical and pharmaceutical industry. The cutting-edge inventions developed in this space and now available for sale have endless possibilities – most importantly improved medical care and enhanced quality of life – when matched with the right buyer," says Dean Becker, CEO of ICAP Patent Brokerage.

Patent Portfolios for Sale
The assets available for sale disclose key innovations relevant to these exciting technology sectors, including:

• Material for Orthopedic Applications
• Enhanced Topical Analgesic Cream
• and more!

Click here to see a complete catalog of the pharmaceutical and medical device patent portfolios available for sale.

To learn more about the assets available for sale:
Contact Paul Greco of ICAP Patent Brokerage at (212) 815-6692 or via email at [email protected].

Follow us on Twitter (@ICAP_Auction_IP) and join our LinkedIn group.

About ICAP Patent Brokerage

ICAP Patent Brokerage is a division of ICAP plc and the world's largest intellectual property brokerage and patent auction firm.

About ICAP

ICAP is a leading markets operator and provider of post trade risk mitigation and information services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, FX, emerging markets and equity derivatives through voice and electronic networks. Through its post trade risk mitigation and information services ICAP helps customers manage and mitigate risks in their portfolios. For more information, go to www.icap.com.

SOURCE ICAP Patent Brokerage

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED